Topiroxostat API

Name	Topiroxostat
Chinese name	托匹司他
Cas Number	577778-58-6
Source	India
Qualifications	-/-/-/-/-

Topipristat, developed by Japan's Fuji Pharmaceutical Company, is a new type of highly selective and reversible xanthine oxidase inhibitor. It was approved for marketing in Japan on June 28, 2013 for gout and hyperuricemia. Topipristat is used to treat gout and hyperuricemia. There are many patients with this indication in China and the market is huge. With the improvement of people's living standards and changes in diet, the incidence of gout has increased year by year in recent years. The market for febuxostat, a similar product that went on the market in the early years, has grown rapidly, and the current market capacity has reached a medium-scale level. Although Topipristat has not yet been listed in the United States, Europe and other countries, there is huge market and clinical demand, and the future market prospects are promising.

Hot Tags: topiroxostat api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Gabapentin API, Fulvestrant API, Troxagliptin Succinate API, Idebenone API, Temozolomide API, Linagliptin API

• Previous: Protein Iron Succinate API
• Next: Ramelteon API